株式会社iXgene
Tokyo, JP · 2 known investors
Find your way into 株式会社iXgene
32 people in our graph share verified history with the 株式会社iXgene team — schools, employers, funds. One of them is your warm intro.
Carlos Domingounlockedknows Atsushi Mizuno · together at Tokyo Institute of Technology (overlapped)
×11knows the team · via Tokyo Institute of Technology
iXgene develops regenerative medicine therapies using genome-edited induced pluripotent stem cells (iPSCs) to treat conditions including glioblastoma and traumatic brain injury. The company focuses on gene and cell therapies derived from genetically engineered stem cells.
Founders & leadership
TF
Toshiharu Furukawa
AM
Atsushi MizunoinAtsushi Mizuno is co-founder and COO of iXgene, a regenerative medicine company developing iPSC-based therapies for brain conditions. He holds a PhD in Biotechnology and has experience in life science startups and university technology commercialization.
Investors · 2
Frequently asked questions
- What does 株式会社iXgene do?
- iXgene develops regenerative medicine therapies using genome-edited induced pluripotent stem cells (iPSCs) to treat conditions including glioblastoma and traumatic brain injury. The company focuses on gene and cell therapies derived from genetically engineered stem cells.
- Who founded 株式会社iXgene?
- 株式会社iXgene was founded by Toshiharu Furukawa, Atsushi Mizuno.
- Who are 株式会社iXgene's investors?
- 株式会社iXgene's investors include Keio Innovation Initiative, UTokyo Innovation Platform Co. Ltd..
- Where is 株式会社iXgene headquartered?
- 株式会社iXgene is headquartered in Tokyo, JP.